Variables | Stroke Patients | Controls |
---|
SP (n = 25) | LEI (n = 25) | SP (n = 25) | LEI (n = 25) |
---|
AH | UH | AH | UH |
---|
MAP, mmHg | 109.2 (5.7)# | 103.0 (5.5)# | 90.0 (6.1) | 89.2 (3.9) |
CBFv, cm.s−1 | 47.5 (6.3)# | 55.1 (5.8) | 41.7 (2.4)* | 45.03 (2.8) | 60.3(11.6) | 53.8 (5.5) |
CrCP, mm Hg | 18.2 (6.7) | 18.0 (4.6) | 19.4 (5.0) | 17.0 (5.5) | 14.2 (4.47) | 15.5 (8.0) |
RAP, mmHg.s.cm− 1 | 1.97 (0.32)*# | 1.76 (0.25)# | 2.25 (0.23)*# | 1.77 (0.17)# | 1.56 (0.27) | 1.65 (0.60) |
- Data are presented as mean (SD)
- LEI Leicester, UK SP, Sao Paulo, Brazil, AH affected hemisphere, UH unaffected hemisphere, MAP Mean arterial pressure, CBFv Cerebral blood flow velocity, CrCP Critical closing pressure, RAP Resistance Area Product
- *p < 0.01, Tukey’s post-hoc test for comparisons between stroke affected and unaffected hemispheres
- #p < 0.05, Tukey’s post-hoc test for comparisons between controls and stroke participants (same geographical region)